Skip to main content

Grafa News and Videos — Page 1156

Grafa Headlines

Latest

Grafa

BeOne Medicines showcases sustained leukemia control with long-term Brukinsa data

BeOne Medicines (NASDAQ:ONC) is moving to advance the treatment paradigm for chronic lymphocytic leukemia (CLL) with extensive long-term follow-up data slated for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Read more: BeOne Medicines showcases sustained leukemia control with long-term Brukinsa data
Grafa
Technology

Dell surges 40% as blockbuster AI server demand triggers forecast upgrades

Shares of Dell Technologies (NYSE:DELL) soared nearly 40% in premarket trading on Friday after robust demand for its Nvidia-powered artificial intelligence servers prompted the hardware giant to sharply raise its annual revenue and profit forecasts.

Read more: Dell surges 40% as blockbuster AI server demand triggers forecast upgrades
Grafa
Oil and Gas

Oil steadies near $94 but heads for steepest weekly loss since April on Iran deal hopes

Oil prices stabilized on Friday but remained on track for their sharpest weekly decline since early April, as investors weighed reports of a tentative ceasefire extension between the U.S. and Iran against a backdrop of lingering political hurdles.

Read more: Oil steadies near $94 but heads for steepest weekly loss since April on Iran deal hopes
Grafa

FDA approves AstraZeneca's Imfinzi combination for high-risk bladder cancer

The U.S. Food and Drug Administration approved AstraZeneca's (NYSE:AZN) blockbusting immunotherapy Imfinzi (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy, marking a major regulatory expansion for the company’s oncology franchise into earlier-stage disease.

Read more: FDA approves AstraZeneca's Imfinzi combination for high-risk bladder cancer

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift